Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanfeng Tongqiao Diwan for Upper Airway Cough Syndrome
ChiCTR2300069302Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sanfeng Tongqiao Diwan in post-nasal drip (PND) (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Symptom relief score at day 14. Started Jul 2020; status: completed.
02
Drugs
Sanfeng Tongqiao Diwan
03
Conditions
post-nasal drip (PND)
Beyond the preview
Go deeper on ChiCTR2300069302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069302.